UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 28, 2020~~April 3, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-25121

SLEEP NUMBER CORPORATION

(Exact name of registrant as specified in its charter)


Minnesota						41-1597886
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

1001 Third Avenue South

Minneapolis,

Minnesota

55404

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (763) 551-7000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

SNBR

Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x NO ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x NO ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO x

As of ~~March 28, 2020, 27,636,000~~April 3, 2021, 24,464,000 shares of the registrant’s Common Stock were outstanding.

Table of contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

INDEX

Table of contents

PART I: FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(unaudited - in thousands, except per share amounts)


		March 28, 2020		December 28, 2019			April 3, 2021		January 2, 2021
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	239,213	$	1,593	Cash and cash equivalents	$	2,238	$	4,243
Accounts receivable, net of allowance for doubtful accounts of $1,067 and $898, respectively		7,170		19,978
Accounts receivable, net of allowances of $1,028 and $1,046, respectively						Accounts receivable, net of allowances of $1,028 and $1,046, respectively	25,923		31,871
Inventories	Inventories	82,021		87,065		Inventories	82,308		81,362
Prepaid expenses	Prepaid expenses	13,492		15,335		Prepaid expenses	27,189		20,839
Other current assets	Other current assets	30,889		36,397		Other current assets	33,844		43,489
Total current assets	Total current assets	372,785		160,368		Total current assets	171,502		181,804

Non-current assets:	Non-current assets:					Non-current assets:
Property and equipment, net	Property and equipment, net	194,707		197,421		Property and equipment, net	182,113		175,223
Operating lease right-of-use assets	Operating lease right-of-use assets	323,770		327,017		Operating lease right-of-use assets	329,714		314,226
Goodwill and intangible assets, net	Goodwill and intangible assets, net	72,681		73,226		Goodwill and intangible assets, net	72,270		72,871
Other non-current assets	Other non-current assets	49,871		48,011		Other non-current assets	66,610		56,012
Total assets	Total assets	$	1,013,814	$	806,043	Total assets	$	822,209	$	800,136

Liabilities and Shareholders’ Deficit	Liabilities and Shareholders’ Deficit					Liabilities and Shareholders’ Deficit
Current liabilities:	Current liabilities:					Current liabilities:
Borrowings under revolving credit facility		$	446,003	$	231,000
Borrowings under credit facility						Borrowings under credit facility	$	314,900	$	244,200
Accounts payable	Accounts payable	132,939		134,594		Accounts payable	122,098		91,904
Customer prepayments	Customer prepayments	25,816		34,248		Customer prepayments	92,569		72,017
Accrued sales returns	Accrued sales returns	22,273		19,809		Accrued sales returns	24,610		24,765
Compensation and benefits	Compensation and benefits	27,292		40,321		Compensation and benefits	42,185		76,786
Taxes and withholding	Taxes and withholding	27,490		22,171		Taxes and withholding	39,098		23,339
Operating lease liabilities	Operating lease liabilities	60,210		59,561		Operating lease liabilities	64,076		62,077
Other current liabilities	Other current liabilities	53,054		53,070		Other current liabilities	57,833		60,856
Total current liabilities	Total current liabilities	795,077		594,774		Total current liabilities	757,369		655,944

Non-current liabilities:	Non-current liabilities:					Non-current liabilities:
Deferred income taxes	Deferred income taxes	9,142		3,808		Deferred income taxes	1,757		242
Operating lease liabilities	Operating lease liabilities	294,548		298,090		Operating lease liabilities	298,475		283,084
Other non-current liabilities	Other non-current liabilities	70,956		68,802		Other non-current liabilities	97,258		84,844
Total liabilities	Total liabilities	1,169,723		965,474		Total liabilities	1,154,859		1,024,114

Shareholders’ deficit:	Shareholders’ deficit:					Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, 0 shares issued and outstanding	Undesignated preferred stock; 5,000 shares authorized, 0 shares issued and outstanding	—		—		Undesignated preferred stock; 5,000 shares authorized, 0 shares issued and outstanding	0		0
Common stock, $0.01 par value; 142,500 shares authorized, 27,636 and 27,961 shares issued and outstanding, respectively		276		280
Common stock, $0.01 par value; 142,500 shares authorized, 24,464 and 25,390 shares issued and outstanding, respectively						Common stock, $0.01 par value; 142,500 shares authorized, 24,464 and 25,390 shares issued and outstanding, respectively	245		254
Additional paid-in capital	Additional paid-in capital	—		—		Additional paid-in capital	0		0
Accumulated deficit	Accumulated deficit	(156,185)		(159,711)		Accumulated deficit	(332,895)		(224,232)
Total shareholders’ deficit	Total shareholders’ deficit	(155,909)		(159,431)		Total shareholders’ deficit	(332,650)		(223,978)
Total liabilities and shareholders’ deficit	Total liabilities and shareholders’ deficit	$	1,013,814	$	806,043	Total liabilities and shareholders’ deficit	$	822,209	$	800,136

See accompanying notes to condensed consolidated financial statements.

Table of contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(unaudited - in thousands, except per share amounts)


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020
Net sales	Net sales	$	472,566	$	426,445	Net sales	$	568,256	$	472,566
Cost of sales	Cost of sales	170,435		164,212		Cost of sales	212,338		170,435
Gross profit	Gross profit	302,131		262,233		Gross profit	355,918		302,131

Operating expenses:	Operating expenses:					Operating expenses:
Sales and marketing	Sales and marketing	207,744		186,827		Sales and marketing	223,617		207,744
General and administrative	General and administrative	31,072		34,323		General and administrative	42,592		31,072
Research and development	Research and development	10,501		8,376		Research and development	13,286		10,501
Total operating expenses	Total operating expenses	249,317		229,526		Total operating expenses	279,495		249,317
Operating income	Operating income	52,814		32,707		Operating income	76,423		52,814
Interest expense, net	Interest expense, net	2,344		2,609		Interest expense, net	977		2,344
Income before income taxes	Income before income taxes	50,470		30,098		Income before income taxes	75,446		50,470
Income tax expense	Income tax expense	11,330		4,680		Income tax expense	8,812		11,330
Net income	Net income	$	39,140	$	25,418	Net income	$	66,634	$	39,140

Basic net income per share:	Basic net income per share:					Basic net income per share:
Net income per share – basic	Net income per share – basic	$	1.40	$	0.83	Net income per share – basic	$	2.63	$	1.40
Weighted-average shares – basic	Weighted-average shares – basic	27,858		30,620		Weighted-average shares – basic	25,377		27,858

Diluted net income per share:	Diluted net income per share:					Diluted net income per share:
Net income per share – diluted	Net income per share – diluted	$	1.36	$	0.80	Net income per share – diluted	$	2.51	$	1.36
Weighted-average shares – diluted	Weighted-average shares – diluted	28,772		31,738		Weighted-average shares – diluted	26,544		28,772

See accompanying notes to condensed consolidated financial statements.

Table of contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Statements of Shareholders’ Deficit

(unaudited - in thousands)


		Common Stock					Additional Paid-in Capital		Accumulated Deficit				Total	Common Stock						Additional Paid-in Capital			Accumulated Deficit				Total
		Shares	Amount													Shares			Amount			Additional Paid-in Capital			Accumulated Deficit			Total
Balance at December 28, 2019		27,961	$	280	$	—	$	(159,711)	$	(159,431)
Balance at January 2, 2021											Balance at January 2, 2021	25,390		$	254		$	0		$	(224,232)				$	(223,978)
Net income	Net income	—	—		—		39,140		39,140		Net income	—		—			—			66,634			66,634
Exercise of common stock options	Exercise of common stock options	167	1		3,282		—		3,283		Exercise of common stock options	106		1			2,459			—			2,460
Stock-based compensation	Stock-based compensation	396	4		2,047		—		2,051		Stock-based compensation	314		3			6,413			—			6,416
Repurchases of common stock	Repurchases of common stock	(888)	(9)		(5,329)		(35,614)		(40,952)		Repurchases of common stock	(1,346)		(13)			(8,872)			(175,297)			(184,182)

Balance at March 28, 2020		27,636	$	276	$	—	$	(156,185)	$	(155,909)
Balance at April 3, 2021											Balance at April 3, 2021	24,464		$	245		$	0		$	(332,895)		$	(332,650)


		Common Stock					Additional Paid-in Capital		Accumulated Deficit				Total	Common Stock						Additional Paid-in Capital			Accumulated Deficit				Total
		Shares	Amount													Shares			Amount			Additional Paid-in Capital			Accumulated Deficit			Total
Balance at December 29, 2018		30,868	$	309	$	—	$	(109,859)	$	(109,550)
Balance at December 28, 2019											Balance at December 28, 2019	27,961		$	280		$	0		$	(159,711)				$	(159,431)
Net income	Net income	—	—		—		25,418		25,418		Net income	—		—			—			39,140			39,140
Exercise of common stock options	Exercise of common stock options	151	2		2,834		—		2,836		Exercise of common stock options	167		1			3,282			—			3,283
Stock-based compensation	Stock-based compensation	364	3		3,635		—		3,638		Stock-based compensation	396		4			2,047			—			2,051
Repurchases of common stock	Repurchases of common stock	(1,170)	(12)		(6,469)		(40,501)		(46,982)		Repurchases of common stock	(888)		(9)			(5,329)			(35,614)			(40,952)

Balance at March 30, 2019		30,213	$	302	$	—	$	(124,942)	$	(124,640)
Balance at March 28, 2020											Balance at March 28, 2020	27,636		$	276		$	0		$	(156,185)		$	(155,909)

See accompanying notes to condensed consolidated financial statements.

Table of contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(unaudited - in thousands)

Three Months Ended
March 28,
2020 March 30,
2019
Cash flows from operating activities:
Net income $ 39,140 $ 25,418
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 15,371 15,743
Stock-based compensation 2,051 3,638
Net gain on disposals and impairments of assets (22) (433)
Deferred income taxes 5,334 824
Changes in operating assets and liabilities:
Accounts receivable 12,808 6,182
Inventories 5,044 1,568
Income taxes 5,798 4,208
Prepaid expenses and other assets 7,478 (5,283)
Accounts payable 11,282 5,857
Customer prepayments (8,432) 3,452
Accrued compensation and benefits (13,157) 1,750
Other taxes and withholding (479) 1,254
Other accruals and liabilities 2,725 3,958
Net cash provided by operating activities 84,941 68,136
Cash flows from investing activities:
Purchases of property and equipment (10,351) (19,743)
Proceeds from sales of property and equipment 25 2,571
Net cash used in investing activities (10,326) (17,172)
Cash flows from financing activities:
Repurchases of common stock (41,445) (55,656)
Net increase in short-term borrowings 201,170 2,955
Proceeds from issuance of common stock 3,283 2,836
Debt issuance costs (3) (1,015)
Net cash provided by (used in) financing activities 163,005 (50,880)
Net increase in cash and cash equivalents 237,620 84
Cash and cash equivalents, at beginning of period 1,593 1,612
Cash and cash equivalents, at end of period $ 239,213 $ 1,696


	Three Months Ended
	April 3, 2021		March 28, 2020
Cash flows from operating activities:
Net income	$	66,634	$	39,140
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,638		15,371
Stock-based compensation	6,416		2,051
Net loss (gain) on disposals and impairments of assets	78		(22)
Deferred income taxes	1,515		5,334
Changes in operating assets and liabilities:
Accounts receivable	5,948		12,808
Inventories	(946)		5,044
Income taxes	6,847		5,798
Prepaid expenses and other assets	(3,113)		7,478
Accounts payable	12,390		11,282
Customer prepayments	20,552		(8,432)
Accrued compensation and benefits	(34,605)		(13,157)
Other taxes and withholding	8,912		(479)
Other accruals and liabilities	6,332		2,725
Net cash provided by operating activities	111,598		84,941

Cash flows from investing activities:
Purchases of property and equipment	(11,546)		(10,351)
Proceeds from sales of property and equipment	12		25

Net cash used in investing activities	(11,534)		(10,326)

Cash flows from financing activities:
Repurchases of common stock	(178,613)		(41,445)
Net increase in short-term borrowings	74,087		201,170
Proceeds from issuance of common stock	2,460		3,283
Debt issuance costs	(3)		(3)
Net cash (used in) provided by financing activities	(102,069)		163,005

Net (decrease) increase in cash and cash equivalents	(2,005)		237,620
Cash and cash equivalents, at beginning of period	4,243		1,593
Cash and cash equivalents, at end of period	$	2,238	$	239,213

See accompanying notes to condensed consolidated financial statements.

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

1. Business and Summary of Significant Accounting Policies

Business & Basis of Presentation

We prepared the condensed consolidated financial statements as of and for the three months ended ~~March 28, 2020~~April 3, 2021 of Sleep Number Corporation and our 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of ~~March 28, 2020~~April 3, 2021 and ~~December 28, 2019,~~January 2, 2021, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period. Additionally, based on the duration and severity of the current global situation involving the novel coronavirus (COVID-19) pandemic, including but not limited to general economic conditions, consumer confidence, store closings mandated by federal, state or local authorities and possible supply chain disruptions, the extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended ~~December 28, 2019~~January 2, 2021 and other recent filings with the SEC.

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. In addition, during the current environment involving COVID-19, predicting future events will be especially challenging for management. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material. Our critical accounting policies consist of stock-based compensation, ~~goodwill and indefinite-lived intangible assets,~~ warranty liabilities and revenue recognition.

The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.

~~New Accounting Pronouncements~~

~~Accounting Guidance Not Yet Adopted~~

~~In April 2020, the Financial Accounting Standards Board (FASB) issued a Staff Q&A,~~ ~~Topic 842 and 840: Accounting For Lease Concessions Related to the Effects of the COVID-19 Pandemic~~. To provide clarity in response to the COVID-19 pandemic crisis, the FASB staff believes that it would be acceptable for entities to make an election to account for lease concessions related to the effects of the COVID-19 pandemic consistent with how those concessions would be accounted for under Topic 842 as though enforceable rights and obligations for those concessions existed (regardless of whether those enforceable rights and obligations for the concessions explicitly exist in the contract).

Consequently, for concessions related to the effects of the COVID-19 pandemic, we will not have to analyze each contract to determine whether enforceable rights and obligations for concessions exist in the contract and can elect to apply or not apply the lease modification guidance in Topic 842 to those contracts. This election is available for concessions related to the effects of the COVID-19 pandemic that do not result in a substantial increase in the rights of the lessor or our obligations as the lessee. For example, this election is available for concessions that result in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The FASB staff expects that reasonable judgment will be exercised in making those determinations. Some concessions will provide a deferral of payments with no substantive changes to the consideration in the original contract. A deferral affects the timing, but the amount of the consideration is substantially the same as that required by the original contract. The staff expects that there will be multiple ways to account for those deferrals, none of which the staff believes are more preferable than the others. Two of those methods are:

~~Table of Contents~~

~~SLEEP NUMBER CORPORATION~~

~~AND SUBSIDIARIES~~

~~Notes to Condensed Consolidated Financial Statements~~

~~(unaudited)~~

a.Account for the concessions as if no changes to the lease contract were made. Under that accounting, a lessor would increase its lease receivable, and a lessee would increase its accounts payable as receivables/payments accrue. In its income statement, a lessor would continue to recognize income, and a lessee would continue to recognize expense during the deferral period.

b.~~Account for the deferred payments as variable lease payments.~~

We are evaluating the effect of the new guidance on our condensed consolidated financial statements and related disclosures, and plan to select election method b. above. Under this election, deferred payments would be treated as variable rent payments, resulting in an adjustment to expense in the period in which they arise.

2. Fair Value Measurements

At ~~March 28, 2020~~April 3, 2021 and ~~December 28, 2019,~~January 2, 2021, we had $9$16 million and $8$12 million, respectively, of debt and equity securities that fund our deferred compensation plan and are classified in other non-current assets. We also had corresponding deferred compensation plan liabilities of $9$16 million and $8$12 million at ~~March 28, 2020~~April 3, 2021 and ~~December 28, 2019,~~January 2, 2021, respectively, which are included in other non-current liabilities. The majority of the debt and equity securities are Level 1 as they trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis. Unrealized gains/(losses) on the debt and equity securities offset those associated with the corresponding deferred compensation plan liabilities.

3. Inventories

Inventories consisted of the following (in thousands):


		March 28, 2020		December 28, 2019			April 3, 2021		January 2, 2021
Raw materials	Raw materials	$	4,905	$	6,231	Raw materials	$	10,496	$	12,599
Work in progress	Work in progress	81		31		Work in progress	88		103
Finished goods	Finished goods	77,035		80,803		Finished goods	71,724		68,660
		$	82,021	$	87,065		$	82,308	$	81,362

~~4. Goodwill and Intangible Assets, Net~~

~~Goodwill and Indefinite-Lived Intangible Assets~~

~~Goodwill was $64 million at March 28, 2020 and December 28, 2019. Indefinite-lived trade name/trademarks totaled $1.4 million at March 28, 2020 and December 28, 2019.~~

~~Definite-Lived Intangible Assets~~

The gross carrying amount of our developed technologies was $19 million at March 28, 2020 and December 28, 2019. Accumulated amortization was $12 million and $11 million at March 28, 2020 and December 28, 2019, respectively.

Amortization expense for both the three months ended March 28, 2020 and March 30, 2019, was $0.5 million. Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):

March 28,
2020
2020 (excluding the three months ended March 28, 2020) $ 1,668
2021 2,181
2022 2,181
2023 1,209
Thereafter —
Total future amortization for definite-lived intangible assets $ 7,239

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

4. Goodwill and Intangible Assets, Net

Goodwill and Indefinite-lived Intangible Assets

Goodwill was $64 million at April 3, 2021 and January 2, 2021. Indefinite-lived trade name/trademarks totaled $1.4 million at April 3, 2021 and January 2, 2021.

Definite-lived Intangible Assets

The gross carrying amount of our developed technologies was $19 million at April 3, 2021 and January 2, 2021. Accumulated amortization was $14 million and $13 million at April 3, 2021 and January 2, 2021, respectively. Amortization expense for both the three months ended April 3, 2021 and March 28, 2020, was $0.5 million.

The gross carrying amount of our patents, which were acquired in June 2020, was $2 million at April 3, 2021 and January 2, 2021, respectively. Accumulated amortization was $0.2 million and $0.1 million at April 3, 2021 and January 2, 2021, respectively. Amortization expense for the three months ended April 3, 2021 was $55 thousand.

Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):


2021 (excluding the three months ended April 3, 2021)	$	1,802
2022	2,403
2023	1,431
2024	222
2025	226
2026	222
Thereafter	522
Total future amortization for definite-lived intangible assets	$	6,828

5. Credit Agreement

Our ~~revolving~~ credit facility as of ~~March 28, 2020,~~April 3, 2021, had a net aggregate availability of $450 million. The credit facility is for general corporate purposes, ~~and~~ to meet our seasonal working capital ~~requirements.~~requirements and to repurchase our stock. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio (4.5x) and a minimum interest coverage ratio (3.0x). Under the terms of the credit agreement, we pay a variable rate of interest and a commitment fee based on our leverage ratio. ~~The credit agreement matures in February 2024.~~ We were in compliance with all financial covenants as of ~~March 28, 2020.~~

On March 17, 2020, we borrowed an additional $262 million under our credit agreement, which represented all remaining amounts then available under the credit agreement. The additional borrowings were undertaken as a precautionary measure to provide increased liquidity and preserve financial flexibility in light of current disruption and uncertainty resulting from the COVID-19 pandemic.April 3, 2021.

The following table summarizes our borrowings under the credit facility ($ in thousands):

March 28,
2020 December 28,
2019
Outstanding borrowings $ 446,003 $ 231,000
Outstanding letters of credit $ 3,997 $ 3,497
Additional borrowing capacity $ — $ 215,503
Weighted-average interest rate 2.9 % 3.5 %

On April 3, 2020, we amended the credit agreement to add a 364-day term loan facility up to an aggregate commitment of $75 million under our credit agreement for a total commitment amount of $525 million, with another $75 million available under our accordion (subject to lenders' approval). We fully drew down the term loan and secured an initial interest rate of approximately 3.27%, which is equal to the one-month LIBOR rate plus the applicable margin based on the then-current total leverage ratio. In addition, the amendment: (a) increases the floor for loans based on LIBOR to at least 0.75% and (b) prohibits the use of proceeds of the revolving loan, term loan or letters of credit under the credit agreement, as amended, to make capital distributions (as defined in the credit agreement, as amended, to include, among other items, dividends and share repurchases). No financial covenants were amended. The additional borrowings were undertaken as a precautionary measure to provide increased liquidity and preserve financial flexibility in light of current disruption and uncertainty resulting from the COVID-19 pandemic. Proceeds may be used in the future for working capital and other general corporate purposes permitted by the credit agreement, as amended.


	April 3, 2021			January 2, 2021
Outstanding borrowings	$	314,900		$	244,200
Outstanding letters of credit	$	3,997		$	3,997
Additional borrowing capacity	$	131,103		$	201,803
Weighted-average interest rate	1.5		%	1.5		%

On April 21, 2021, we amended our revolving credit facility to increase our net aggregate availability from $450 million to $600 million. We maintained the accordion feature which allows us to increase the amount of the credit facility from $600 million to $800 million, subject to lenders’ approval. The amended credit facility matures in February 2024. There were no other significant changes to the credit facility’s terms and conditions.

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

6. Leases

We lease our retail, office and manufacturing space under operating leases which, in addition to the minimum lease payments, may require payment of a proportionate share of the real estate taxes and certain building operating expenses. While our local market development approach generally results in long-term participation in given markets, our retail store leases generally provide for an initial lease term of five to 10 years. Our office and manufacturing leases provide for an initial lease term of up to 15 years. In addition, our mall-based retail store leases may require payment of variable rent based on net sales in excess of certain thresholds. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at our sole discretion. Lease options are included in the lease term only if exercise is reasonably certain at lease commencement. Our lease agreements do not contain any material residual value guarantees. We also lease vehicles and certain equipment under operating leases with an initial lease term of three to five years.

Our operating lease costs include facility, vehicle and equipment lease costs, but exclude variable lease costs. Operating lease costs are recognized on a straight-line basis over the lease term, after consideration of rent escalations and rent holidays. The lease term for purposes of the calculation begins on the earlier of the lease commencement date or the date we take possession of the property. During lease renewal negotiations that extend beyond the original lease term, we estimate straight-line rent expense based on current market conditions. Variable lease costs are recorded when it is probable the cost has been incurred and the amount can be reasonably estimated. Future payments for real estate taxes and certain building operating expenses for which we are obligated are not included in operating lease costs.

At ~~March 28, 2020,~~April 3, 2021, our finance right-of-use assets and lease liabilities were not significant.

Lease costs were as follows (in thousands):


	Three Months Ended
	April 3, 2021		March 28, 2020
Operating lease costs(1)	$	23,638	$	22,949
Variable lease costs	$	515	$	12

___________________________

(1)Includes short-term lease costs which are not significant.

The maturities of operating lease liabilities as of April 3, 2021, were as follows(1) (in thousands):


2021 (excluding the three months ended April 3, 2021)	$	65,248
2022	79,974
2023	69,962
2024	58,098
2025	49,146
2026	39,853
Thereafter	83,392
Total operating lease payments(2)	445,673
Less: Interest	83,059
Present value of operating lease liabilities(3)	$	362,614

___________________________

(1)During 2020, we deferred certain cash lease payments to future periods. At April 3, 2021, we had deferred cash rent payments of $2.6 million which are excluded from this table and are included in Other current liabilities and Other non-current liabilities.

(2)Total operating lease payments exclude $92 million of legally binding minimum lease payments for leases signed but not yet commenced.

(3)Includes the current portion of $64 million for operating lease liabilities.

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

~~Operating lease costs were as follows (in thousands):~~

Three Months Ended
March 28,
2020 March 30,
2019
Operating lease costs⁽¹⁾
$ 22,949 $ 21,056
Variable lease costs $ 12 $ 499

~~___________________________~~

⁽¹⁾~~Includes short-term lease costs which are not significant.~~

~~The maturities of operating lease liabilities as of March 28, 2020, were as follows (in thousands):~~

2020 (excluding the three months ended March 28, 2020)⁽¹⁾
63,309
2021 78,083
2022 69,672
2023 59,702
2024 47,918
2025 39,059
Thereafter 88,488
Total lease payments⁽²⁾
446,231
Less: Interest 91,473
Present value of operating lease liabilities⁽³⁾
$ 354,758

~~___________________________~~

⁽¹⁾Subsequent to March 28, 2020, we renegotiated certain operating leases to defer approximately $3 million in lease payments from 2020 to future periods in response to store closings mandated by federal, state or local authorities and other economic issues related to COVID-19.

⁽²⁾~~Total lease payments exclude $62 million of legally binding minimum lease payments for leases signed but not yet commenced.~~

⁽³⁾~~Includes the current portion of $60 million for operating lease liabilities.~~

Other information related to operating leases was as follows:


		March 28, 2020		December 28, 2019			April 3, 2021		January 2, 2021
Weighted-average remaining lease term (years)	Weighted-average remaining lease term (years)	6.5		6.6		Weighted-average remaining lease term (years)	6.4		6.3
Weighted-average discount rate	Weighted-average discount rate	7.1	%	7.2	%	Weighted-average discount rate	6.7	%	6.9	%


		Three Months Ended							Three Months Ended
(in thousands)	(in thousands)	March 28, 2020		March 30, 2019		(in thousands)	April 3, 2021		March 28, 2020
Cash paid for amounts included in present value of operating lease liabilities	Cash paid for amounts included in present value of operating lease liabilities	$	21,469	$	19,757	Cash paid for amounts included in present value of operating lease liabilities	$	21,386	$	21,469
Right-of-use assets obtained in exchange for operating lease liabilities	Right-of-use assets obtained in exchange for operating lease liabilities	$	10,954	$	16,153	Right-of-use assets obtained in exchange for operating lease liabilities	$	29,454	$	10,954

~~Table of Contents~~

~~SLEEP NUMBER CORPORATION~~

~~AND SUBSIDIARIES~~

~~Notes to Condensed Consolidated Financial Statements~~

~~(unaudited)~~

7. Repurchases of Common Stock

Repurchases of our common stock were as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020
Amount repurchased under Board-approved share repurchase program	Amount repurchased under Board-approved share repurchase program	$	38,111	$	40,900	Amount repurchased under Board-approved share repurchase program	$	167,418	$	38,111
Amount repurchased in connection with the vesting of employee restricted stock grants	Amount repurchased in connection with the vesting of employee restricted stock grants	2,841		6,082		Amount repurchased in connection with the vesting of employee restricted stock grants	16,764		2,841
Total amount repurchased (based on trade dates)	Total amount repurchased (based on trade dates)	$	40,952	$	46,982	Total amount repurchased (based on trade dates)	$	184,182	$	40,952

AsEffective as of ~~March 28, 2020, the~~April 4, 2021, our Board of Director approved an increase in our total remaining ~~authorization under our Board-approved~~ share repurchase ~~program was $437~~authorization to $600 million.

~~In light of the uncertainty surrounding the impact of COVID-19, we have suspended all share repurchases under our Board-approved share repurchase program.~~

8. Revenue Recognition

Deferred contract assets and deferred contract liabilities are included in our condensed consolidated balance sheets as follows (in thousands):


		March 28, 2020		December 28, 2019			April 3, 2021		January 2, 2021
Deferred Contract Assets included in:	Deferred Contract Assets included in:					Deferred Contract Assets included in:
Other current assets	Other current assets	$	24,408	$	23,568	Other current assets	$	23,924	$	26,593
Other non-current assets	Other non-current assets	35,078		33,782		Other non-current assets	45,075		37,976
		$	59,486	$	57,350		$	68,999	$	64,569


		March 28, 2020		December 28, 2019			April 3, 2021		January 2, 2021
Deferred Contract Liabilities included in:	Deferred Contract Liabilities included in:					Deferred Contract Liabilities included in:
Other current liabilities	Other current liabilities	$	34,515	$	34,204	Other current liabilities	$	31,623	$	35,288
Other non-current liabilities	Other non-current liabilities	46,512		44,970		Other non-current liabilities	58,736		49,689
		$	81,027	$	79,174		$	90,359	$	84,977

During the three months ended April 3, 2021 and March 28, 2020, ~~and March 30, 2019,~~ we recognized revenue of ~~$10~~$7 million and $9$10 million, ~~respectively,~~ that were included in the deferred contract liability balances at the beginning of the respective periods.

Revenue from goods and services transferred to customers at a point in time accounted for approximately 99% and 98% of our revenues for ~~both~~ the three months ended April 3, 2021 and March 28, 2020, ~~and March 30, 2019.~~

~~Net sales from each of our channels was as follows (in thousands):~~

Three Months Ended
March 28,
2020 March 30,
2019
Retail $ 435,357 $ 392,226
Online and phone 35,917 29,763
Company-Controlled channel 471,274 421,989
Wholesale/Other channel 1,292 4,456
Total $ 472,566 $ 426,445

respectively.

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

Net sales were as follows (in thousands):


	Three Months Ended
	April 3, 2021		March 28, 2020
Retail stores	$	489,188	$	435,357
Online, phone, chat and other	79,068		37,209
Total Company	$	568,256	$	472,566

Obligation for Sales Returns

The activity in the sales returns liability account was as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020
Balance at beginning of year	Balance at beginning of year	$	19,809	$	19,907	Balance at beginning of year	$	24,765	$	19,809
Additions that reduce net sales	Additions that reduce net sales	22,258		21,726		Additions that reduce net sales	23,711		22,258
Deductions from reserves	Deductions from reserves	(19,794)		(21,676)		Deductions from reserves	(23,866)		(19,794)
Balance at end of period	Balance at end of period	$	22,273	$	19,957	Balance at end of period	$	24,610	$	22,273

9. Stock-Based Compensation Expense

Total stock-based compensation expense was as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020
Stock awards	Stock awards	$	1,405	$	3,033	Stock awards	$	5,808	$	1,405
Stock options	Stock options	646		605		Stock options	608		646
Total stock-based compensation expense ⁽¹⁾	Total stock-based compensation expense ⁽¹⁾	2,051		3,638		Total stock-based compensation expense (1)	6,416		2,051
Income tax benefit	Income tax benefit	496		898		Income tax benefit	1,598		496
Total stock-based compensation expense, net of tax	Total stock-based compensation expense, net of tax	$	1,555	$	2,740	Total stock-based compensation expense, net of tax	$	4,818	$	1,555

^{___________________________}

(1) ~~Decrease~~Changes in ~~2020~~ stock-based compensation expense ~~reflects~~reflect the cumulative impact of the change in the expected achievements of certain performance targets.

10. Profit Sharing and 401(k) Plan

Under our profit sharing and 401(k) plan, eligible employees may defer up to 50% of their compensation on a pre-tax basis, subject to Internal Revenue Service limitations. Each pay period, we may make a discretionary contribution equal to a percentage of the employee’s contribution. During the three months ended April 3, 2021 and March 28, 2020, ~~and March 30, 2019,~~ our contributions, net of forfeitures, were ~~$1.6~~$1.9 million and ~~$1.5~~$1.6 million, respectively.

~~Effective May 2020, we suspended making discretionary 401(k) plan contributions for the remainder of fiscal year 2020.~~

~~11. Net Income per Common Share~~

~~The components of basic and diluted net income per share were as follows (in thousands, except per share amounts):~~

Three Months Ended
March 28,
2020 March 30,
2019
Net income $ 39,140 $ 25,418
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding 27,858 30,620
Dilutive effect of stock-based awards 914 1,118
Diluted weighted-average shares outstanding 28,772 31,738
Net income per share – basic $ 1.40 $ 0.83
Net income per share – diluted $ 1.36 $ 0.80

~~For the three months ended March 28, 2020 and March 30, 2019, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial.~~

109

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

11. Net Income per Common Share

The components of basic and diluted net income per share were as follows (in thousands, except per share amounts):


	Three Months Ended
	April 3, 2021		March 28, 2020
Net income	$	66,634	$	39,140
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding	25,377		27,858
Dilutive effect of stock-based awards	1,167		914
Diluted weighted-average shares outstanding	26,544		28,772
Net income per share – basic	$	2.63	$	1.40
Net income per share – diluted	$	2.51	$	1.36

For the three months ended April 3, 2021 and March 28, 2020, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial.

12. Commitments and Contingencies

Warranty Liabilities

The activity in the accrued warranty liabilities account was as follows (in thousands):


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020
Balance at beginning of year	Balance at beginning of year	$	11,345	$	10,389	Balance at beginning of year	$	12,152	$	11,345
Additions charged to costs and expenses for current-year sales	Additions charged to costs and expenses for current-year sales	2,628		3,192		Additions charged to costs and expenses for current-year sales	4,330		2,628
Deductions from reserves	Deductions from reserves	(2,779)		(3,127)		Deductions from reserves	(4,717)		(2,779)
Changes in liability for pre-existing warranties during the current year, including expirations	Changes in liability for pre-existing warranties during the current year, including expirations	297		1,166		Changes in liability for pre-existing warranties during the current year, including expirations	(156)		297
Balance at end of period	Balance at end of period	$	11,491	$	11,620	Balance at end of period	$	11,609	$	11,491

Legal Proceedings

We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with U.S. generally accepted accounting principles, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. If a material loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible material losses either because we believe that we have valid defenses to claims asserted against us, the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate, or the potential loss is not material. We currently do not expect the outcome of pending legal proceedings to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.

On September 18, 2018, two former Home Delivery team members filed suit, now venued in San Diego County Superior Court, ~~in Fresno County,~~ California, alleging representative claims on a purported class action basis under the California Labor Code Private Attorney General Act. While the two representative plaintiffs were in the Home Delivery workforce, the Complaint does not limit the purported plaintiff class to that group. The plaintiffs allege that Sleep Number failed or refused to adopt adequate practices, policies and procedures relating to wage payments, record keeping, employment disclosures, meal and rest breaks, among other claims, under California law. The Complaint sought damages in the form of civil penalties and plaintiffs’ attorneys’ fees. The parties have executed a settlement agreement, ~~pending Court approval, which includes~~including the settlement and release of certain additional related claims that are contained in a consolidated complaint, ~~currently pending in San Diego County Superior Court. We intend~~

Table of Contents

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Notes to ~~continue vigorously defending this matter in the event~~Condensed Consolidated Financial Statements

(unaudited)

which received preliminary Court approval on July 29, 2020. On January 8, 2021, the Court ~~does not approve~~granted final approval of the ~~settlement.~~parties' settlement and any right to appeal the final approval expired on April 6, 2021. Sleep Number has satisfied its obligations under the settlement and all that remains are the administrative steps related to the distribution to be performed by the claims administrator.

On March 27, 2018, Level Sleep, LLC (Level Sleep) filed a patent infringement lawsuit against Sleep Number in the Federal District Court for the Eastern District of Texas. In its Complaint, Level Sleep claims that Sleep Number infringed two patents owned by Level Sleep, U.S. Patent Nos. 6,807,698 and 7,036,172 (the Patents), by, among other things, making, using, offering for sale, or selling within the United States, and/or importing into the United States, beds with sleep surfaces having foam with multiple zones in the longitudinal direction. Level Sleep has asserted that five non-360^® beds no longer sold and two current non-360 beds infringe the Patents. Level Sleep seeks damages in the form of a reasonable royalty. Sleep Number has asserted that the Patents are invalid and that our products do not infringe the Patents. On January 14, 2020, the Court granted summary judgment in favor of Sleep Number, finding that Sleep Number’s products do not infringe the Patents. Level Sleep has filed ~~a notice of~~an appeal of the Court’s summary judgment ~~order.~~order, which was heard by the Federal Circuit Court of Appeals on January 5, 2021, and we are awaiting a decision. We intend to continue vigorously defending this matter.

~~Table of Contents~~

~~SLEEP NUMBER CORPORATION~~

~~AND SUBSIDIARIES~~

~~Notes to Condensed Consolidated Financial Statements~~

~~(unaudited)~~

13. COVID-19 Pandemic

~~The~~At the onset of the COVID-19 pandemic ~~and ensuing~~in mid-March 2020, government restrictions ~~have~~ resulted in the temporary closure of most of our retail stores, ~~since mid-March.~~ ~~The pandemic has impacted~~with 47% of our ~~revenue growth and will adversely impact our financial performance.~~ ~~The length and severity~~stores closed on average during the second quarter of 2020. While prioritizing the ~~reduction in consumer demand due to the pandemic and the impact on our future financial performance remains uncertain.~~

I~~n response to the pandemic, we have taken decisive actions to focus on the health and~~ safety of our team, ~~members~~serving our customers and ~~customers, strengthening~~ensuring business continuity, we swiftly took decisive actions to strengthen our liquidity, cash flows and financial position, and ~~mitigating~~mitigate the future impact on our operations and financial performance.

The pandemic mainly impacted our second quarter of 2020 financial performance, as we generated strong financial performance during the full-year of 2020 and the first quarterly period ended April 3, 2021. However, the pandemic's future effect on consumer demand and our ongoing financial performance remains uncertain. See Item 2. Management's Discussion and Analysis of Financial ~~Conditions~~Condition and Results of Operations and Part II: Item 1A. Risk Factors for additional discussion on the COVID-19 pandemic and the impact on our business.

1211

Index

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a reader of our condensed consolidated financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in eight sections:

•Forward-Looking Statements and Risk Factors

•Business Overview

•COVID-19 Pandemic - Impact on our Business

•Results of Operations

•Liquidity and Capital Resources

•Non-GAAP Data Reconciliations

•Off-Balance-Sheet Arrangements and Contractual Obligations

•Critical Accounting Policies

Forward-Looking Statements and Risk Factors

The discussion in this Quarterly Report contains certain forward-looking statements that relate to future plans, events, financial results or performance. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or the negative of these or similar terms. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, among others:

•Current and future general and industry economic trends and consumer confidence;

•Risks inherent in outbreaks of pandemics or contagious disease, including the COVID-19 pandemic;

•The effectiveness of our marketing messages;

•The efficiency of our advertising and promotional efforts;

•Our ability to execute our ~~Company-Controlled~~Total Retail distribution strategy;

•Our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates;

•Our ability to continue to improve and expand our product line, and consumer acceptance of our products, product quality, innovation and brand image;

•Industry competition, the emergence of additional competitive products and the adequacy of our intellectual property rights to protect our products and brand from competitive or infringing activities;

•Claims that our products, processes, advertising, or trademarks infringe the intellectual property rights of others;

•Availability of attractive and cost-effective consumer credit options;

•Our manufacturing processes with minimal levels of inventory, which may leave us vulnerable to shortages in supply;

•Our dependence on significant suppliers and third parties and our ability to maintain relationships with key suppliers or third-parties, including several sole-source suppliers or providers of services;

•Rising commodity costs and other inflationary pressures;

•Risks inherent in global sourcing activities, including tariffs, outbreaks of pandemics or contagious diseases, strikes and the potential for shortages in supply;

•Risks of disruption in the operation of any of our main manufacturing facilities or assembly facilities;

•Increasing government regulation;

•Pending or unforeseen litigation and the potential for adverse publicity associated with litigation;

•The adequacy of our and third-party information systems to meet the evolving needs of our business and existing and evolving risks and regulatory standards applicable to data privacy and security;

•The costs and potential disruptions to our business related to upgrading our information systems;

•The vulnerability of our and third-party information systems to attacks by hackers or other cyber threats that could compromise the security of our systems, result in a data breach or disrupt our business; and

•Our ability to attract, retain and motivate qualified management, executive and other key team members, including qualified retail sales professionals and managers.

Additional information concerning these, and other risks and uncertainties is contained under the caption “Risk Factors” below in Part II: Item 1A of this Quarterly Report on Form 10-Q and under the same caption in our Annual Report on Form 10-K.

We have no obligation to publicly update or revise any of the forward-looking statements contained in this Quarterly Report on Form 10-Q.

1312

~~Index~~

Business Overview

Individuality is core to Sleep Number. Our purpose driven Company is comprised of over 5,000 passionate team members who

are dedicated to our mission of improving lives by individualizing sleep experiences. Our 360 smart beds provide each sleeper with

adjustable, personalized comfort for proven quality sleep. We have already improved over 13 million lives as we strive to positively impact the lives of our customers and society. Sleep science and data are the foundation of our innovations. Our award-winning 360smart beds benefit from our proprietary SleepIQ technology – integrating over 9 billion hours of highly accurate sleep data – to provide effortless comfort and individualized sleep health insights, including a daily SleepIQ score.

As a purpose driven ~~company~~Company in health and wellness, Sleep Number is ~~the~~a leader in sleep innovation. Our vertically integrated business model and role as the exclusive designer, manufacturer, marketer, retailer and servicer of Sleep Number^® beds allows us to offer consumers high-quality, individualized sleep solutions and services.

We generate revenue by marketing our innovations directly to new and existing customers, and selling products through our Stores, Online, Phone and Chat (Total Retail).

We are committed to delivering superior shareholder value by: (1) increasing consumer demand; (2) leveraging our business model; and (3) deploying capital efficiently.

COVID-19 Pandemic - Impact on our Business

~~The~~At the onset of the COVID-19 pandemic ~~and ensuing~~in mid-March 2020, government restrictions ~~have~~ resulted in the temporary closure of most of our retail stores, ~~since mid-March.~~ ~~The pandemic has impacted~~with 47% of our ~~revenue growth~~stores closed on average during the second quarter of 2020. While prioritizing the safety of our team, serving our customers and ~~will adversely impact~~ensuring business continuity, we swiftly took decisive actions to strengthen our liquidity, cash flows and financial ~~performance.~~ ~~The length~~position, and ~~severity of~~mitigate the ~~reduction in consumer demand due to the pandemic and the~~future impact on our operations and financial performance.

The pandemic mainly impacted our second quarter of 2020 financial performance, as we generated strong financial performance during the full-year of 2020 and the first quarterly period ended April 3, 2021. However, the pandemic's future effects on consumer demand and our ongoing financial performance remains uncertain. See Part I: Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II: Item 1A. Risk Factors for ~~further~~additional discussion ~~of the adverse impacts of~~on the COVID-19 pandemic ~~on our business.~~

~~In response to~~and the ~~pandemic, we have taken decisive actions to focus on the health and safety of our team members and customers, strengthening our liquidity, cash flows and financial position, and mitigating the future~~ impact on our ~~operations and financial performance. These measures include, but are not limited to, the following:~~

~~Health and Safety of our Team Members and Customers.~~ As the COVID-19 pandemic has developed, we have taken numerous steps to support our team members and customers in practicing social distancing. In addition, we have implemented numerous other practices in our stores, manufacturing facilities and operations based on the Centers for Disease Control and Prevention’s (CDC) recommendations.

~~Expense Management.~~ ~~With the reduction in revenue growth, we have, and will continue to implement cost cutting actions, including:~~

•~~We furloughed nearly 40% of our team members with another 30% working reduced hours.~~

•A significant amount of our team members’ compensation depends on Company performance against pre-determined goals and changes in shareholder value. Our CEO will not receive any cash compensation for the balance of the year through a 50% deferral and exchanging all remaining salary for restricted stock units. In addition, our board and most of our leadership team reduced their cash compensation in exchange for restricted stock units. All team members’ compensation has been meaningfully reduced through variable compensation programs and other actions.

•~~We temporarily suspended our 401(k) match and selected other employee benefit programs.~~

•~~We reduced our sales and marketing expenses, and temporarily suspended virtually all discretionary projects across the company.~~

•~~We are negotiating rent deferrals and abatements for stores closed due to COVID-19.~~

~~Liquidity, Cash Flows and Financial Position.~~ ~~We have taken the following actions to preserve cash, increase liquidity and strengthen our financial position:~~

•~~Drew down the remaining availability under our revolving credit facility on March 17, 2020. Cash and cash equivalents at March 28, 2020 totaled $239 million.~~

•~~Added $75 million of additional cash on April 3, 2020 through an incremental 364-day term loan under our credit facility’s $150 million accordion.~~

•~~Suspended share repurchases for the remainder of 2020.~~

•~~Reduced 2020 planned capital expenditures to approximately $35 million versus $59 million in 2019.~~

~~CARES Act. On March 27, 2020, the President signed the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) into law. The CARES Act includes the following relief, among others:~~

•~~Amended federal tax laws to permit 100% bonus depreciation for eligible qualified improvement property placed in service by the taxpayer after December 31, 2017 and before January 1, 2023.~~

•Employers are eligible for a 50 percent refundable payroll tax credit on wages paid up to $10,000 during the crisis. The credit would be available to employers whose businesses were disrupted due to virus shutdowns and those that had a decrease in gross receipts of 50 percent or more when compared to the same quarter last year. The credit can be claimed for employees who are retained but not currently working due to the crisis for firms with more than 100 employees.

~~Index~~

•Provides for deferred payment of the employer portion of social security taxes through the end of 2020, with 50% of the deferred amount due December 31, 2021 and the remaining 50% due December 31, 2022. This will provide us with additional liquidity during 2020.business.

Results of Operations

Quarterly and Year-to-Date Results

Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including increases or decreases in sales, timing, amount and effectiveness of advertising expenditures, changes in sales return rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/closings and related expenses, changes in net sales resulting from changes in our store base, timing of new product introductions and related expenses, timing of promotional offerings, competitive factors, changes in commodity costs, disruptions in supplies or third-party service providers, seasonality of retail and bedding industry sales, consumer confidence and general economic conditions. In addition, based on the duration and severity of the current global situation involving the COVID-19 pandemic, the extent to which our business and our condensed consolidated financial results are impacted, will depend on future developments, which are highly uncertain and cannot be predicted. Therefore, our historical results of operations may not be indicative of the results that may be achieved for any future period.

Highlights

Financial highlights for the three months ended ~~March 28, 2020~~April 3, 2021 were as follows:

•The COVID-19 pandemic and ensuing government restrictions have resulted in the temporary closure of most of our retail stores since mid-March. We have taken decisive action to manage liquidity and costs through the challenging economic environment caused by the COVID-19 pandemic. For additional details, see "COVID-19 Pandemic - Impact on our Business" above.

•Net sales for the three months ended ~~March 28, 2020~~April 3, 2021 increased ~~11%~~20% to ~~$473~~$568 million, compared with ~~$426~~$473 million for the same period one year ago.

•The ~~11%~~20% net sales increase ~~resulted from~~included a 7%20% comparable sales increase in ~~our Company-Controlled channel~~Total Retail, including strong growth in online, phone and ~~5 percentage points (ppt.) of sales growth from 26 net new stores opened in the past 12 months.~~chat sales. For additional details, see the components of total net sales change on page ~~17.~~15.

•Sales per store ~~(Company-Controlled channel sales~~(sales for stores open at least one year, Total Retail, including online, phone and ~~phone~~chat sales) on a trailing twelve-month basis for the period ended ~~March 28, 2020~~April 3, 2021 totaled ~~$2.9~~$3.2 million, 7%9% higher than the same period ~~one year ago.~~last year.

•Operating income for the three months ended ~~March 28, 2020~~April 3, 2021 was ~~$53~~$76 million, an increase of ~~61%,~~$24 million, or ~~$20 million,~~45%, compared with ~~$33~~$53 million in the prior-year period. ~~Our~~The $24 million increase in operating income ~~rate increased to 11.2% of~~was driven by the 20% increase in net sales ~~compared~~and

a 3.6 percentage points (ppt.) reduction in our operating expenses rate, partially offset by a 1.3 ppt. decrease in the gross profit rate.

•The gross profit rate decrease of 1.3 ppt. was primarily due to reinstated incentive compensation (minimal incentive compensation was recorded in the first quarter of 2020 based on the economic uncertainty related to the pandemic), and inflationary cost pressures and higher supply chain costs associated with ~~7.7% of~~temporary supply constraints, partially offset by the leverage from the 20% net sales ~~for the same period last year.~~increase.

•~~Operating income and~~The 3.6 ppt. reduction in our operating ~~income~~expenses rate ~~for~~was mainly due to the leveraging impact of the 20% net sales increase. During the three months ended March 28, 2020 were positively impacted by the 11% increase in net sales and a 2.4 ppt. improvement in the gross profit rate. The 2.4 ppt. gross profit rate improvement was primarily due to three factors: (i) a favorable sales mix of higher-margin products; (ii) reduced warranty expenses; and (iii) current-period manufacturing efficiency gains. In addition, operating income for the current-year period included a $6.2 million reduction in broad-based incentive compensation, partially offset by $2.6 million of COVID-19 disruption related payroll expenses.

•~~During the three-months ended March 28, 2020,~~April 3, 2021, we continued to prioritize investments in near- and long-term growth drivers, including ~~a 25% increase in our innovation driving~~$13.3 million of R&D ~~expenses.~~expenses, 27% more than the same period one year ago.

•Net income for the three months ended ~~March 28, 2020~~April 3, 2021 increased ~~54%~~by 70% to ~~$39~~$67 million, compared with ~~$25~~net income of $39 million for the same period one year ago. ~~Earnings~~Net income per diluted share ~~were $1.36, up 70%~~was $2.51, an 85% increase compared with ~~$0.80~~net income per diluted share of $1.36 last year.

•We achieved a return on invested capital (ROIC) of 27.6% on a trailing twelve-month basis for the period ended April 3, 2021, compared with 19.1% for the comparable period one year ago.

•Cash provided by operating activities for the three months ended ~~March 28, 2020~~April 3, 2021 increased by ~~$17~~$27 million, or ~~25%~~31%, to ~~$85~~$112 million, compared with ~~$68~~$85 million for the same period one year ago.

•Cash and cash equivalents at March 28, 2020 totaled $239 million, including drawing down the then remaining availability under our revolving credit facility on March 17, 2020 in response to the COVID-19 pandemic. At ~~March 28, 2020,~~April 3, 2021, we had ~~$446~~$315 million of borrowings under our revolving credit facility. Net liquidity available under our revolving credit facility was $131 million at April 3, 2021.

•On April ~~3, 2020,~~21, 2021, we ~~entered into a $75 million 364-day term loan under~~amended our revolving credit facility ~~and drew down~~to expand the ~~full amount.~~aggregate availability from $450 million to $600 million. We also replenished our outstanding share repurchase authorization to $600 million effective at the beginning of the fiscal second quarter, April 4, 2021. We remain committed to our capital deployment priorities focused on performance drivers.

~~Index~~

The following table sets forth our results of operations expressed as dollars and percentages of net sales. Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.


		Three Months Ended															Three Months Ended
		March 28, 2020						March 30, 2019							April 3, 2021				March 28, 2020
Net sales	Net sales	$	472.6	100.0	%	$	426.4	100.0	%	Net sales	$	568.3	100.0	%	$	472.6	100.0	%
Cost of sales	Cost of sales	170.4		36.1	%	164.2		38.5	%	Cost of sales	212.3		37.4	%	170.4		36.1	%
Gross profit	Gross profit	302.1		63.9	%	262.2		61.5	%	Gross profit	355.9		62.6	%	302.1		63.9	%
Operating expenses:	Operating expenses:									Operating expenses:
Sales and marketing	Sales and marketing	207.7		44.0	%	186.8		43.8	%	Sales and marketing	223.6		39.4	%	207.7		44.0	%
General and administrative	General and administrative	31.1		6.6	%	34.3		8.0	%	General and administrative	42.6		7.5	%	31.1		6.6	%
Research and development	Research and development	10.5		2.2	%	8.4		2.0	%	Research and development	13.3		2.3	%	10.5		2.2	%
Total operating expenses	Total operating expenses	249.3		52.8	%	229.5		53.8	%	Total operating expenses	279.5		49.2	%	249.3		52.8	%
Operating income	Operating income	52.8		11.2	%	32.7		7.7	%	Operating income	76.4		13.4	%	52.8		11.2	%
Interest expense, net	Interest expense, net	2.3		0.5	%	2.6		0.6	%	Interest expense, net	1.0		0.2	%	2.3		0.5	%
Income before income taxes	Income before income taxes	50.5		10.7	%	30.1		7.1	%	Income before income taxes	75.4		13.3	%	50.5		10.7	%
Income tax expense	Income tax expense	11.3		2.4	%	4.7		1.1	%	Income tax expense	8.8		1.6	%	11.3		2.4	%
Net income	Net income	$	39.1	8.3	%	$	25.4	6.0	%	Net income	$	66.6	11.7	%	$	39.1	8.3	%

Net income per share:	Net income per share:									Net income per share:
Basic	Basic	$	1.40			$	0.83			Basic	$	2.63			$	1.40
Diluted	Diluted	$	1.36			$	0.80			Diluted	$	2.51			$	1.36

Weighted-average number of common shares:	Weighted-average number of common shares:									Weighted-average number of common shares:
Basic	Basic	27.9				30.6				Basic	25.4				27.9
Diluted	Diluted	28.8				31.7				Diluted	26.5				28.8

The percentage of our total net sales, by dollar volume, ~~from each of our channels~~ was as follows:

Three Months Ended
March 28,
2020 March 30,
2019
Company-Controlled channel 99.7 % 99.0 %
Wholesale/Other channel 0.3 % 1.0 %
Total 100.0 % 100.0 %


	Three Months Ended
	April 3, 2021		March 28, 2020
Retail stores	86.1	%	92.1	%
Online, phone, chat and other	13.9	%	7.9	%
Total Company	100.0	%	100.0	%

~~Index~~

The components of total net sales change, including comparable net sales changes, were as follows:

Three Months Ended
March 28,
2020 March 30,
2019
Sales change rates:
Retail comparable-store sales ⁽¹⁾
6 % 5 %
Online and phone 21 % 6 %
Company-Controlled comparable sales change ⁽¹⁾
7 % 5 %
Net opened/closed stores 5 % 5 %
Total Company-Controlled channel 12 % 10 %
Wholesale/Other channel (71 %) (3 %)
Total net sales change 11 % 10 %


	Three Months Ended
	April 3, 2021		March 28, 2020
Sales change rates:
Retail comparable-store sales (1)	12	%	6	%
Online, phone and chat	116	%	21	%
Total Retail comparable sales change (1)	20	%	7	%
Net opened/closed stores and other	0	%	4	%
Total Company	20	%	11	%

___________________________

⁽¹⁾Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned within the same shopping center remain in the comparable-store base.

Other sales metrics were as follows:


		Three Months Ended										Three Months Ended
		March 28, 2020			March 30, 2019				April 3, 2021			March 28, 2020
Average sales per store ⁽¹⁾ ($ in thousands)		$	2,932		$	2,744
Average sales per store (1)(4) ($ in thousands)								Average sales per store (1)(4) ($ in thousands)	$	3,196		$	2,932
Average sales per square foot ⁽¹⁾⁽⁴⁾	Average sales per square foot ⁽¹⁾⁽⁴⁾	$	1,040		$	1,003		Average sales per square foot ⁽¹⁾⁽⁴⁾	$	1,095		$	1,040
Stores > $2 million in net sales ⁽²⁾⁽⁴⁾	Stores > $2 million in net sales ⁽²⁾⁽⁴⁾	71		%	66		%	Stores > $2 million in net sales ⁽²⁾⁽⁴⁾	71		%	71		%
Stores > $3 million in net sales ⁽²⁾⁽⁴⁾	Stores > $3 million in net sales ⁽²⁾⁽⁴⁾	32		%	26		%	Stores > $3 million in net sales ⁽²⁾⁽⁴⁾	33		%	32		%
Average revenue per mattress unit – Company-Controlled channel ⁽³⁾		$	4,884		$	4,804
Average revenue per mattress unit (3)								Average revenue per mattress unit (3)	$	5,030		$	4,884

___________________________

⁽¹⁾Trailing-twelve months ~~Company-Controlled~~Total Retail comparable sales per store open at least one year.

⁽²⁾Trailing-twelve months for stores open at least one year (excludes online, phone and ~~phone~~chat sales).

⁽³⁾Represents ~~Company-Controlled channel total~~Total Retail (stores, online, phone and chat) net sales divided by ~~Company-Controlled channel~~Total Retail mattress units.

(4)Fiscal 2020 included 53 weeks, as compared to 52 weeks in fiscal 2021 and 2019. The additional week in 2020 was in the fiscal fourth quarter. Total Retail comparable sales have been adjusted to remove the estimated impact of the additional week on those metrics.

The number of retail stores operating was as follows:


		Three Months Ended				Three Months Ended
		March 28, 2020	March 30, 2019		April 3, 2021	March 28, 2020
Beginning of period	Beginning of period	611	579	Beginning of period	602	611
Opened	Opened	8	15	Opened	11	8
Closed	Closed	(8)	(9)	Closed	(6)	(8)
End of period	End of period	611	585	End of period	607	611

1715

~~Index~~

Comparison of Three Months Ended ~~March 28, 2020~~April 3, 2021 with Three Months Ended March ~~30, 2019~~28, 2020

Net sales

Net sales for the three months ended ~~March 28, 2020~~April 3, 2021 increased by ~~$46~~$96 million, or ~~11%~~20%, to ~~$473~~$568 million, compared with ~~$426~~$473 million for the same period one year ago. The COVID-19 pandemic and ensuing government restrictions have resulted in the temporary closure of most of our retail stores since mid-March. For additional details, see "COVID-19 Pandemic - Impact on our Business" above.

The ~~11%~~20% net sales increase ~~resulted from~~consisted primarily of a 7%20% comparable sales increase in ~~our Company-Controlled channel and 5 percentage points (ppt.) of sales growth from 26 net new stores opened in the past 12 months.~~Total Retail. For additional details, see the components of total net sales change on page ~~17.~~15. Online, phone and chat sales (included in comparable sales noted above) made up 14% of total net sales compared with 8% in the prior year as consumers embrace transacting remotely with Sleep Number as well as in our stores.

The ~~$46~~$96 million net sales increase compared with the same period one year ago was comprised of the following: (i) a ~~$30~~$90 million increase in our ~~Company-Controlled~~Total Retail comparable net sales; and (ii) a ~~$19~~$6 million increase ~~resulting~~ from net store openings. ~~Wholesale/Other channel sales decreased slightly year-over-year. Company-Controlled~~Total Retail mattress unit sales increased ~~10%~~17% compared with the prior year. ~~Average~~Total Retail average revenue per mattress unit ~~in our Company-Controlled channel totaled $4,884, a 2% increase~~increased by 3% to $5,030, compared with ~~$4,804~~$4,884 in the prior-year period.

Gross profit

Gross profit of ~~$302~~$356 million increased by ~~$40~~$54 million, or ~~15%~~18%, compared with ~~$262~~$302 million for the same period one year ago. The gross profit rate ~~improved to 63.9%~~was 62.6% of net sales for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with ~~61.5%~~63.9% for the prior-year comparable period. The current-year gross profit rate ~~increase~~decrease of ~~2.4~~1.3 ppt. was ~~primarily~~mainly due to: (i) increased performance-based incentive compensation expense (0.5 ppt.; minimal incentive compensation was recorded in the first quarter of 2020 based on the economic uncertainty related to ~~three factors: (i) a favorable sales mix of higher-margin products (1.2 ppt.)~~the pandemic); (ii) ~~reduced warranty expenses~~inflationary cost pressures and higher supply chain costs associated with temporary supply constraints (0.5 ppt.); and (iii) ~~current-period manufacturing efficiency gains~~other miscellaneous items, including product mix (0.6 ppt.); partially offset by (iv) leverage from the 20% net sales increase (0.3 ppt.). In addition, our gross profit rate will fluctuate from quarter to quarter due to a variety of other factors, including return and exchange ~~costs, and performance-based incentive compensation.~~costs.

Sales and marketing expenses

Sales and marketing expenses for the three months ended ~~March 28, 2020~~April 3, 2021 were ~~$208~~$224 million, or ~~44.0%~~39.4% of net sales, compared with ~~$187~~$208 million, or ~~43.8%~~44.0% of net sales, for the same period one year ago. The~~0.2ppt. increase in the~~ current-year sales and marketing ~~expense~~expenses rate decrease of 4.6 ppt. was ~~mainly~~primarily due to: (i) ~~a 16% increase in media expenses that drove additional customer traffic to our~~the leveraging impact of the 20% net sales ~~channels, including stores, online and phone;~~increase; and (ii) ~~COVID-19 disruption related payroll costs; partially offset~~efficiency gains through our digital ecosystem and operating initiatives. Efficiency gains and operating initiatives included leveraging our media spending, which increased by ~~(iii)~~17% compared with the ~~expense leverage from the 11% increase in~~prior year, while net ~~sales.~~sales increased by 20%, and improved store operating productivity.

General and administrative expenses

General and administrative (G&A) expenses totaled ~~$31~~$43 million, or ~~6.6%~~7.5% of net sales, for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with ~~$34~~$31 million, or ~~8.0%~~6.6% of net sales, in the prior-year period. The ~~$3.3~~$12 million ~~decrease~~increase in G&A expenses consisted primarily of: (i) a ~~$5.0~~$13.9 million ~~decrease~~increase in employee compensation primarily resulting from a year-over-year ~~decrease~~increase in company-wide performance-based incentive ~~compensation;~~compensation (minimal incentive compensation was recorded in the first quarter of 2020 based on the economic uncertainty related to the pandemic); partially offset by (ii) a ~~$1.7~~$2.4 million ~~increase~~decrease in ~~professional fees~~travel expenses and other miscellaneous expenses. The G&A ~~expense~~expenses rate ~~decreased~~increased by ~~1.4~~0.9 ppt. in the current-year period, compared with the same period one year ago due to the items discussed above, ~~and~~partially offset by the leveraging impact of the ~~11%~~20% net sales increase.

Research and development expenses

Research and development (R&D) expenses increased by ~~25%~~27% to ~~$11~~$13.3 million for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with $8$10.5 million for the same period ~~one~~last year ~~ago. The R&D expense rate for the three months ended March 28, 2020 increased~~as we continued to ~~2.2% of net sales, compared with 2.0% of net sales for the prior year. The spending level increase supports~~prioritize our ~~consumer~~long-term innovation ~~strategy.~~initiatives.

Interest expense, net

Interest expense, net decreased to ~~$2.3~~$1.0 million for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with ~~$2.6~~$2.3 million for the same period one year ago. The ~~$0.3~~$1.4 million decrease was mainly driven by a ~~reduction~~lower level of outstanding borrowings during the three months ended April 3, 2021 and a decrease in the weighted-average interest rate on borrowings, ~~outstanding during the three months ended March 28, 2020~~ compared with the same period one year ago.

~~Index~~

Income tax expense

Income tax expense totaled ~~$11~~$9 million for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with $5$11 million last year. The effective income tax rate for the three months ended ~~March 28, 2020~~April 3, 2021 was ~~22.4%~~11.7%, compared with ~~15.5%~~22.4% for the comparable period last year, reflecting ~~higher~~ stock-based compensation excess tax benefits of $10 million in the ~~prior-year period.~~current-year period compared with approximately $1 million last year.

Liquidity and Capital Resources

Managing our liquidity and capital resources is an important part of our commitment to deliver superior shareholder value. The COVID-19 pandemic and ensuing government restrictions have resulted in the temporary closure of most of our retail stores since mid-March. We have taken the following decisive actions to manage liquidity and capital resources through the challenging economic environment caused by the COVID-19 pandemic:

•~~On March 17, 2020, we drew down an additional $262 million under our credit agreement, which represented all remaining amounts then available under the facility.~~

•On April 3, 2020, we added a $75 million 364-day term loan under our credit agreement for a total commitment amount of $525 million, with another $75 million available under our accordion (subject to lenders' approval). We fully drew down the term loan and secured an initial interest rate of approximately 3.27%, which is equal to the one-month LIBOR rate plus the applicable margin based on the then-current total leverage ratio. No financial covenants were amended.

•The $262 million and $75 million draws against our credit facility will provide increased liquidity and preserve financial flexibility in consideration of the disruption and uncertainty resulting from the COVID-19 pandemic. Proceeds may be used in the future for working capital and other general corporate purposes as permitted by the credit agreement.

•On April 8, 2020, we announced additional efforts to preserve cash and manage expenses in response to the COVID-19 pandemic including, among other things, discontinuing share repurchases, reducing capital expenditures and negotiating rent deferrals and abatements for stores closed due to COVID-19. We furloughed nearly 40% of our team members with another 30% working reduced hours. Our CEO will not receive any cash compensation for the balance of the year through a 50% deferral and exchanging all remaining salary for restricted stock units. In addition, our Board of Directors and most of our leadership team reduced their cash compensation in exchange for restricted stock units. ~~All team members’ compensation has been meaningfully reduced through variable compensation programs and other actions.~~ We are temporarily suspending the Company's 401(k) match and selected other benefit programs. We also reduced our sales and marketing expenses, and temporarily suspended virtually all discretionary projects.

value over time. Our primary sources of liquidity are ~~the $239 million of cash and cash equivalents on our balance sheet at March 28, 2020, the $75 million that we drew down on April 3, 2020 under our credit facility and future~~ cash flows provided by operating ~~activities. Our cash~~activities and cash ~~equivalents, the~~available under our $600 million revolving credit facility (increased from $450 million to $600 million as of April 21, 2021). The cash generated from ~~future~~ongoing operations and cash available under our revolving credit facility ~~(subject to lenders' approval)~~ are expected to be adequate to maintain operations, and fund anticipated expansion and strategic initiatives for the foreseeable future.

Changes in ~~the~~ cash and cash equivalents during the three months ended ~~March 28, 2020~~April 3, 2021 primarily consisted of ~~$85~~$112 million of cash provided by operating activities and a ~~$201~~$74 million net increase in short-term borrowings, ~~that were partially~~ offset by ~~$10~~$12 million of cash used to purchase property and equipment, and ~~$41~~$179 million of cash used to repurchase our common stock (based on settlement, ~~$38.6~~$162 million under our Board-approved share repurchase program and ~~$2.8~~$17 million in connection with the vesting of employee restricted stock grants).

The following table summarizes our cash flows ($ in millions). Amounts may not add due to rounding differences:


		Three Months Ended							Three Months Ended
		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020
Total cash provided by (used in):	Total cash provided by (used in):					Total cash provided by (used in):
Operating activities	Operating activities	$	84.9	$	68.1	Operating activities	$	111.6	$	84.9
Investing activities	Investing activities	(10.3)		(17.2)		Investing activities	(11.5)		(10.3)
Financing activities	Financing activities	163.0		(50.9)		Financing activities	(102.1)		163.0
Net increase in cash and cash equivalents		$	237.6	$	0.1
Net (decrease) increase in cash and cash equivalents						Net (decrease) increase in cash and cash equivalents	$	(2.0)	$	237.6

Cash provided by operating activities for the three months ended ~~March 28, 2020~~April 3, 2021 was ~~$85~~$112 million, compared with ~~$68~~$85 million for the three months ended March ~~30, 2019.~~28, 2020. Significant components of the year-over-year change in cash provided by operating activities included: (i) a ~~$14~~$27 million increase in net income for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with the same period one year ago; (ii) a ~~$15~~$29 million fluctuation in ~~accrued~~customer prepayments due to strong customer demand during the three months ended April 3, 2021 and temporary supply constraints which extended customer delivery timelines; (iii) a $21 million fluctuation in the amount of compensation and benefits ~~that primarily resulted~~accrued and timing of the related payments resulting from year-over-year changes in ~~company-wide~~Company-wide performance-based incentive ~~compensation that was accrued~~compensation; and ~~paid in the two comparable periods (higher incentive~~

~~Index~~

~~compensation paid in 2020 and lower incentive compensation accrued in the first three months of 2020); (iii) a $13~~(iv) an $11 million fluctuation in prepaid expenses and other assets ~~with~~due to both periods being impacted by the timing of rent payments and prior-year changes in business ~~activities; and (iv) a $12 million fluctuation in customer prepayments~~activities due to the ~~business disruptions resulting from the COVID-19 pandemic and ensuing government restrictions in the second-half of March 2020.~~pandemic.

Net cash used in investing activities to purchase property and equipment was ~~$10~~$12 million for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with ~~$20~~$10 million for the same period one year ago. The year-over-year ~~decrease~~increase was ~~primarily~~ due to ~~the timing of cash flows associated with~~higher property and equipment purchases for new and remodeled ~~stores’ property and equipment. Based on the expected economic impact of COVID-19, we plan to reduce capital expenditures for 2020 to approximately $35 million versus $59 million in 2019.~~stores.

Net cash ~~provided by~~used in financing activities was ~~$163~~$102 million for the three months ended ~~March 28, 2020,~~April 3, 2021, compared with ~~$51 million~~ net cash ~~used in investing activities~~provided by of $163 million for the same period ~~one year ago.~~last year. During the three months ended ~~March 28, 2020,~~April 3, 2021, we repurchased ~~$41~~$179 million of our stock (based on settlement dates, ~~$38.6~~$162 million under our Board-approved share repurchase program and ~~$2.8~~$17 million in connection with the vesting of employee restricted stock awards), compared with ~~$56~~$41 million during the same period one year ago. Short-term borrowings increased by ~~$201~~$74 million during the current-year period due to a ~~$215~~$71 million increase in borrowings under our revolving credit facility to ~~$446~~$315 million ~~partially offset by~~and a ~~decrease~~$3 million increase in book overdrafts which are included in the net change in short-term borrowings. Short-term borrowings increased by $3$201 million during the prior-year period due to a ~~$19~~$215 million increase in borrowings under our revolving credit facility based on uncertainty related to ~~$219 million,~~the pandemic, partially offset by a decrease in book overdrafts.

Under our Board-approved share repurchase program, we repurchased 1.2 million shares at a cost of $167 million (based on trade dates, an average of $136.27 per share) during the three months ended April 3, 2021. During the three months ended March 28, 2020, we repurchased 0.8 million shares at a cost of $38 million (based on trade dates, an average of $49.42 per share) ~~during the three months ended March 28, 2020. During the three months ended March 30, 2019, we repurchased 1.0 million shares at a cost of $41 million (an average of $39.36 per share)~~. ~~The remaining authorization under our Board-approved share repurchase program at March 28, 2020 was $437 million.~~ There is no expiration date governing the period over which we can repurchase shares. ~~In light~~Effective as of ~~the uncertainty surrounding the impact of COVID-19, we have suspended all share repurchases under~~April 4, 2021, our ~~Board-approved~~Board approved an increase in our total remaining share repurchase ~~program.~~authorization to $600 million.

As of ~~March 28, 2020,~~April 3, 2021, we had ~~$446~~$315 million of borrowings under our revolving credit ~~facility and~~facility. We also had $4 million in outstanding letters of credit.Net liquidity available under our credit facility was $131 million at April 3, 2021. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio (4.5x) and a minimum interest coverage ratio (3.0x). Our leverage ratio as defined in our credit agreement was 2.3x as of April 3, 2021. Under the terms of the credit agreement, we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit ~~facility~~agreement is for general corporate purposes, ~~and~~ to meet our seasonal working capital ~~requirements.~~requirements and to repurchase our stock. As of ~~March 28, 2020,~~April 3, 2021, the weighted-average interest rate on borrowings under the credit facility was ~~2.9%~~1.5% and we were in compliance with all financial covenants.

On April 21, 2021, we amended our revolving credit facility to increase our net aggregate availability from $450 million to $600 million. We maintain the accordion feature which allows us to increase the amount of the credit facility from $600 million to $800 million, subject to lenders’ approval. The amended credit facility matures in February 2024. There were no other significant changes to the credit facility’s terms and conditions.

We have an agreement with Synchrony Bank to offer qualified customers revolving credit arrangements to finance purchases from us (Synchrony Agreement). The Synchrony Agreement contains financial covenants consistent with our credit facility, including a maximum leverage ratio and a minimum interest coverage ratio consistent with our credit agreement. As of ~~March 28, 2020,~~April 3, 2021, we were in compliance with all financial covenants.

Under the terms of the Synchrony Agreement, Synchrony Bank sets the minimum acceptable credit ratings, the interest rates, fees and all other terms and conditions of the customer accounts, including collection policies and procedures, and is the owner of the accounts. As the accounts are owned by Synchrony Bank, at no time are the accounts purchased or acquired from us. We are not liable to Synchrony Bank for our customers’ credit defaults.

Index

Non-GAAP Data Reconciliations

Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure.

Our Adjusted EBITDA calculations are as follows (in thousands):


		Three Months Ended						Trailing-Twelve Months Ended							Three Months Ended				Fifty-Three Weeks Ended	Fifty-Two Weeks Ended
		March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020		April 3, 2021		March 28, 2020
Net income	Net income	$	39,140	$	25,418	$	95,567	$	74,409	Net income	$	66,634	$	39,140	$	166,683	$	95,567
Income tax expense	Income tax expense	11,330		4,680		25,313		15,834		Income tax expense	8,812		11,330		34,265		25,313
Interest expense	Interest expense	2,357		2,610		11,338		7,994		Interest expense	978		2,357		7,642		11,338
Depreciation and amortization	Depreciation and amortization	15,253		15,637		61,026		61,673		Depreciation and amortization	14,519		15,253		60,049		61,026
Stock-based compensation	Stock-based compensation	2,051		3,638		15,070		11,966		Stock-based compensation	6,417		2,051		26,179		15,070
Asset impairments	Asset impairments	3		139		49		235		Asset impairments	89		3		388		49
Adjusted EBITDA	Adjusted EBITDA	$	70,134	$	52,122	$	208,363	$	172,111	Adjusted EBITDA	$	97,449	$	70,134	$	295,206	$	208,363

Free Cash Flow

Our “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, “net cash provided by operating activities,” or GAAP financial data. However, we are providing this information as we believe it facilitates analysis for investors and financial analysts.

The following table summarizes our free cash flow calculations (in thousands):


		Three Months Ended						Trailing-Twelve Months Ended							Three Months Ended				Fifty-Three Weeks Ended	Fifty-Two Weeks Ended
		March 28, 2020		March 30, 2019		March 28, 2020		March 30, 2019			April 3, 2021		March 28, 2020		April 3, 2021		March 28, 2020
Net cash provided by operating activities	Net cash provided by operating activities	$	84,941	$	68,136	$	205,965	$	150,420	Net cash provided by operating activities	$	111,598	$	84,941	$	306,318	$	205,965
Subtract: Purchases of property and equipment	Subtract: Purchases of property and equipment	10,351		19,743		49,847		56,453		Subtract: Purchases of property and equipment	11,546		10,351		38,295		49,847
Free cash flow	Free cash flow	$	74,590	$	48,393	$	156,118	$	93,967	Free cash flow	$	100,052	$	74,590	$	268,023	$	156,118

2119

Index

Non-GAAP Data Reconciliations (continued)

Return on Invested Capital (ROIC)

(dollars in thousands)

ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:


		Trailing-Twelve Months Ended										Fifty-Three Weeks Ended			Fifty-Two Weeks Ended
		March 28, 2020			March 30, 2019				April 3, 2021			March 28, 2020
Net operating profit after taxes (NOPAT)	Net operating profit after taxes (NOPAT)							Net operating profit after taxes (NOPAT)
Operating income	Operating income	$	132,203		$	98,234		Operating income	$	208,506		$	132,203
Add: Rent expense ⁽¹⁾	Add: Rent expense ⁽¹⁾	89,237			81,949			Add: Rent expense (1)	92,650			89,237
Add: Interest income	Add: Interest income	15			4			Add: Interest income	84			15
Less: Depreciation on capitalized operating leases ⁽²⁾	Less: Depreciation on capitalized operating leases ⁽²⁾	(22,883)			(20,815)			Less: Depreciation on capitalized operating leases (2)	(24,258)			(22,883)
Less: Income taxes ⁽³⁾	Less: Income taxes ⁽³⁾	(47,453)			(38,490)			Less: Income taxes (3)	(66,118)			(47,453)
NOPAT	NOPAT	$	151,119		$	120,882		NOPAT	$	210,864		$	151,119
Average invested capital	Average invested capital							Average invested capital
Total deficit	Total deficit	$	(155,909)		$	(124,640)		Total deficit	$	(332,650)		$	(155,909)
Less: Cash greater than target ⁽⁴⁾	Less: Cash greater than target ⁽⁴⁾	(113,397)			—			Less: Cash greater than target (4)	—			(113,397)
Add: Long-term debt ⁽⁵⁾	Add: Long-term debt ⁽⁵⁾	446,733			219,533			Add: Long-term debt (5)	315,522			446,733
Add: Capitalized operating lease obligations ⁽⁶⁾	Add: Capitalized operating lease obligations ⁽⁶⁾	713,896			655,592			Add: Capitalized operating lease obligations (6)	741,200			713,896
Total invested capital at end of period	Total invested capital at end of period	$	891,323		$	750,485		Total invested capital at end of period	$	724,072		$	891,323
Average invested capital ⁽⁷⁾	Average invested capital ⁽⁷⁾	$	790,420		$	732,890		Average invested capital (7)	$	763,227		$	790,420
Return on invested capital (ROIC) ⁽⁸⁾	Return on invested capital (ROIC) ⁽⁸⁾	19.1		%	16.5		%	Return on invested capital (ROIC) (8)	27.6		%	19.1		%

___________________________

⁽¹⁾Rent expense is added back to operating income to show the impact of owning versus leasing the related assets.

⁽²⁾Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 6) for the respective reporting periods with an assumed thirty-year useful life. This life assumption is based on our long-term participation in given markets though specific retail location lease commitments ~~which~~ are generally 5 to 10 years at inception. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets.

⁽³⁾Reflects annual effective income tax rates, before discrete adjustments, of 23.9% for both 2021 and ~~24.2% for 2020 and 2019, respectively.~~2020.

⁽⁴⁾Cash greater than target is defined as cash, cash equivalents and marketable debt securities less customer prepayments in excess of $100 million.

⁽⁵⁾Long-term debt includes existing finance lease liabilities.

⁽⁶⁾A multiple of eight times annual rent expense is used as an estimate for capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency.

⁽⁷⁾Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances.

⁽⁸⁾ROIC equals NOPAT divided by average invested capital.

Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

Index

Off-Balance-Sheet Arrangements and Contractual Obligations

As of ~~March 28, 2020,~~April 3, 2021, we were not involved in any unconsolidated special purpose entity transactions. Other than our $4 million in outstanding letters of credit, we do not have any off-balance-sheet financing.

There have been no material changes in our contractual obligations, other than the ~~amendment~~amendments to our credit agreement, since the end of fiscal ~~2019.~~2020. See Note 5, Credit Agreement, of the Notes to our Condensed Consolidated Financial Statements for information regarding our credit agreement. See our Annual Report on Form 10-K for the fiscal year ended ~~December 28, 2019~~January 2, 2021 for additional information regarding our other contractual obligations.

~~Index~~

Critical Accounting Policies

We discuss our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended ~~December 28, 2019.~~January 2, 2021. There were no significant changes in our critical accounting policies since the end of fiscal ~~2019 other than adding goodwill and indefinite-lived intangible assets as a critical accounting policy.~~2020.

~~Description~~

~~Judgments and Uncertainties~~

Effect if Actual Results
Differ from Assumptions

~~Goodwill and Indefinite-Lived Intangible Assets~~

~~Goodwill represents the excess of cost over the fair value of identifiable net assets of businesses acquired. Our indefinite-lived intangible assets include trade names/trademarks.~~

~~See Note 1,~~ ~~Business and Summary of Significant Accounting Policies,~~ ~~and Note 5,~~ ~~Goodwill and Intangible Assets, Net, to the Notes to Consolidated Financial Statements, included in Item 8,~~ ~~Financial Statements and Supplementary Data, of the 2019 Annual Report on Form 10-K, for a complete discussion of our goodwill and indefinite-lived intangible assets.~~

The determination of fair value involves uncertainties because it requires management to make assumptions and to apply judgment to estimate industry and economic factors and the profitability of future business strategies. Management’s assumptions also include projected revenues, operating profit levels and discount rates, as well as consideration of any other factors that may indicate potential impairment.

In the fourth quarter of fiscal 2019, management completed its annual goodwill and other indefinite-lived intangible asset impairment tests and determined there was no impairment. We believe our assumptions and judgments used in estimating cash flows and determining fair value were reasonable. However, unexpected changes to such assumptions and judgments could affect our impairment analyses and future results of operations, including an impairment charge that could be material. There have been no significant changes for the quarter ended March 28, 2020.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in market-based short-term interest rates that will impact our net interest expense. If overall interest rates were one percentage point higher than current rates, our annual net income would decrease by ~~$3.4~~$2.4 million based on the ~~$446~~$315 million of borrowings under our ~~revolving~~ credit facility at ~~March 28, 2020.~~April 3, 2021. We do not manage the interest-rate volatility risk of borrowings under our credit facility through the use of derivative instruments.

ITEM 4. CONTROLS AND PROCEDURES

Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.

Changes in Internal Control

There were no changes in our internal control over financial reporting during the fiscal quarter ended ~~March 28, 2020,~~April 3, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2321

Index

PART II: OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

~~We are involved from time to time in various~~Our legal proceedings ~~arising~~are discussed in Note 12, Commitments and Contingencies, Legal Proceedings, in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with U.S. generally accepted accounting principles, we record a liabilityNotes to Condensed Consolidated Financial Statements in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. If a material loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible material losses either because we believe that we have valid defenses to claims asserted against us, the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate, or the potential loss is not material. We currently do not expect the outcome of pending legal proceedings to have a material effectthis Quarterly Report on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.

On March 27, 2018, Level Sleep, LLC (Level Sleep) filed a patent infringement lawsuit against Sleep Number in the Federal District Court for the Eastern District of Texas. In its Complaint, Level Sleep claims that Sleep Number infringed two patents owned by Level Sleep, U.S. Patent Nos. 6,807,698 and 7,036,172 (the Patents), by, among other things, making, using, offering for sale, or selling within the United States, and/or importing into the United States, beds with sleep surfaces having foam with multiple zones in the longitudinal direction. Level Sleep has asserted that five non-360^® beds no longer sold and two current non-360 beds infringe the Patents. Level Sleep seeks damages in the form of a reasonable royalty. Sleep Number has asserted that the Patents are invalid and that our products do not infringe the Patents. On January 14, 2020, the Court granted summary judgment in favor of Sleep Number, finding that Sleep Number’s products do not infringe the Patents. Level Sleep has filed a notice of appeal of the Court’s summary judgment order. We intend to continue vigorously defending this matter.Form 10-Q.

ITEM 1A. RISK FACTORS

~~In addition to the risks discussed below and other information set forth in this Quarterly Report on Form 10-Q, our~~Our business, financial condition and operating results are subject to a number of risks and uncertainties, including both those that are specific to our business and others that affect all businesses operating in a global environment. Investors should carefully consider the information in this report under the heading, Management’s Discussion and Analysis of Financial Condition and Results of Operationsand also the information under the heading, Risk Factors in our most recent Annual Report on Form 10-K. The risk factors discussed in the Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q do not identify all risks that we face because our business operations could also be affected by additional risk factors that are not presently known to us or that we currently consider to be immaterial to our operations.

~~The COVID-19 pandemic has had, and is expected to continue to have, an adverse effect on our business and our financial results.~~

The outbreak of the COVID-19 pandemic has created significant volatility, uncertainty and economic disruption, which is adversely affecting our business operations and our financial results. As the COVID-19 pandemic continues, consumer fear about becoming ill with the virus and recommendations and/or mandates from federal, state and local authorities to close certain businesses, stay at home, practice social distancing or self-quarantine have increased resulting in the temporary closure of the majority of our stores nationwide since mid-March. These actions have adversely affected our business, operations, demand for our product, traffic to our stores, and macroeconomic factors that affect us, such as consumer confidence and spending which have, in turn resulted in a loss of sales and profits. With most of our retail store locations across the country temporarily closed and our delivery operations adversely impacted, we have shifted to scale our digital capabilities including: remote retail selling, customer service, private appointments, flexible work schedules, solutions for contactless delivery, and remote access for team members across the country. We may further restrict the operations of our stores, delivery operations, and manufacturing and distribution facilities if we deem this necessary or if recommended or mandated by authorities and these measures could have a further material impact on our sales and profits.

In addition, we expect to incur increased costs in our response to the pandemic, including, but not limited to, costs incurred to implement the operational changes described above and certain payments to or other costs relating to team members who are not working during the pandemic.

~~In response to the significant reduction in customer visits to, and spending at, our stores caused by COVID-19, we have taken actions to maintain liquidity including:~~

•~~discontinuing share repurchases;~~

•~~reducing capital expenditures;~~

•~~negotiating rent deferrals and abatements for stores closed due to COVID-19;~~

•~~furloughing nearly 40% of our team members and reducing the working hours of another 30% of our team members;~~

~~Index~~

•~~CEO, board members and most of our leadership team deferred all or a portion of their cash compensation for the balance of the year in exchange for restricted stock units;~~

•~~meaningfully reducing all team members’ compensation through variable compensation programs and other actions;~~

•~~temporarily suspending our 401(k) match and selected other employee benefit programs;~~

•~~reducing our sales and marketing expenses; and~~

•~~temporarily suspending virtually all discretionary projects across the company.~~

It is possible that our cost reduction efforts may be insufficient to maintain adequate liquidity. Also, if we do not respond appropriately to the pandemic, or if customers do not perceive our response to be adequate for a particular region or our company as a whole, we could suffer damage to our reputation and our brand, which could continue to adversely affect our business and financial results in the future.

We are highly dependent on the effectiveness of our marketing messages and the efficiency of our advertising expenditures in generating consumer awareness and sales of our products. In light of our reduced marketing expenses and adjustments to our marketing messages due to COVID-19, we may not be as successful in developing effective messages and achieving efficiency in our advertising expenditures.

Our business depends heavily on the uninterrupted operation of our two main manufacturing plants located in Irmo, South Carolina and Salt Lake City, Utah as well as our assembly distribution centers, two of which are co-located at the manufacturing plants and others located in Baltimore, Maryland and the greater Los Angeles, California area. Our business also depends on the successful operation of our bedding collection fulfillment center in Brooklyn Park, Minnesota and headquarters in Minneapolis, Minnesota. The operation of all of our facilities is critically dependent on our team members who staff these locations, and COVID-19 could directly threaten or impact their health and/or ability to work, and, therefore, adversely affect the operations of our facilities. In addition, governmental mandates or recommendations in these jurisdictions could limit or adversely impact our ability to continue these operations.

COVID-19 also impacted, and may continue to impact, our retail stores, home delivery operations, logistics, and domestic and foreign supply chain, including raw materials and components we source from third parties, particularly as a result of governmental mandates or recommendations.

Our temporary suspension of virtually all discretionary spending across the company and the inability or limitations of certain suppliers, both domestic and foreign, to operate due to governmental mandates or recommendations has delayed and may continue to delay the introduction of new product lines.

~~We have seen, and may continue to see, significant deterioration in macroeconomic factors that typically affect us, such as consumer confidence and spending.~~

The extent and duration of the impact of COVID-19 on our business, operations, and financial results will also depend on future developments, including the duration and spread of the outbreak, governmental mandates and recommendations, and the related impact on consumer confidence and spending, all of which are highly uncertain and unpredictable.

~~Index~~

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) – (b) Not applicable.

Period
Total Number
of Shares
Purchased⁽¹⁾⁽²⁾
Average Price
Paid per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs⁽¹⁾
Approximate
Dollar Value of
Shares that May
Yet Be Purchased
Under the Plans
or Programs⁽³⁾
December 29, 2019 through January 25, 2020 240,764 $ 48.10 238,900 $ 463,993,000
January 26, 2020 through February 22, 2020 224,831 $ 54.37 224,400 $ 451,795,000
February 23, 2020 through March 28, 2020 422,589 $ 40.58 307,886 $ 436,889,000
Total 888,184 $ 46.11 771,186 $ 436,889,000


Period	Total Number of Shares Purchased(1)(2)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(3)
January 3, 2021 through January 30, 2021	30,802	$	81.89	29,700	$	244,471,000
January 31, 2021 through February 27, 2021	256,725	$	129.25	255,000	$	211,501,000
February 28, 2021 through April 3, 2021	1,058,877	$	140.22	943,913	$	79,471,000
Total	1,346,404	$	136.80	1,228,613	$	79,471,000

___________________________

⁽¹⁾Under our Board-approved $500 million share repurchase program (effective September 29, 2019), we repurchased ~~771,186~~1.2 million shares of our common stock at a cost of ~~$38~~$167 million (based on trade dates) during the three months ended ~~March 28, 2020.~~April 3, 2021.

⁽²⁾In connection with the vesting of employee restricted stock grants, we ~~also~~ repurchased ~~116,998~~117,791 shares of our common stock at a cost of ~~$2.8~~$16.8 million during the three months ended ~~March 28, 2020.~~April 3, 2021.

⁽³⁾There is no expiration date governing the period over which we can repurchase shares under our Board-approved share repurchase program. Any repurchased shares are constructively retired and returned to an unissued status. ~~In light~~Effective as of ~~the uncertainty surrounding the impact of COVID-19, we have suspended all share repurchases under~~April 4, 2021, our ~~Board-approved~~Board approved an increase in our total remaining share repurchase ~~program.~~authorization to $600 million.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

2622

Index

ITEM 6. EXHIBITS


Exhibit Number						Description
10.1*						~~Second~~Fifth Amendment to Amended and Restated Credit and Security Agreement, ~~dated~~date d as of April ~~3, 2020~~21, 2021 among Sleep Number Corporation, U.S. Bank National Association and the several banks and other financial institutions from time to time party thereto
10.2*						Form of Non-Statutory Stock Option Award Agreement (Senior Team) under the Sleep Number Corporation 2020 Equity Incentive Plan
10.3*						Form of Performance Adjusted Restricted Stock Unit Award Agreement (ROIC) (Senior Team) under the Sleep Number Corporation 2020 Equity Incentive Plan
10.4*						Form of Restricted Stock Unit Award Agreement (3-Year Ratable) (Sleep Number Labs) under the Sleep Number Corporation 2020 Equity Incentive Plan
10.5*						Form of Restricted Stock Unit Award Agreement (3-Year Cliff Vest) under the Sleep Number Corporation 2020 Equity Incentive Plan
31.1*						Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*						Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*						Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
32.2*						Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
101.INS*						Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH*						Inline XBRL Taxonomy Extension Schema Document
101.CAL*						Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*						Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*						Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*						Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*						Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Filed Herewith

2723

Index

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SLEEP NUMBER CORPORATION

(Registrant)

Dated:

May ~~1, 2020~~7, 2021

By:

/s/ Shelly R. Ibach

Shelly R. Ibach

Chief Executive Officer

(principal executive officer)

By:

/s/ Robert J. Poirier

Robert J. Poirier

Chief Accounting Officer

(principal accounting officer)

2824


	March 28, 2020
2020 (excluding the three months ended March 28, 2020)	$	1,668
2021	2,181
2022	2,181
2023	1,209
Thereafter	—
Total future amortization for definite-lived intangible assets	$	7,239


2020 (excluding the three months ended March 28, 2020)⁽¹⁾	63,309
2021	78,083
2022	69,672
2023	59,702
2024	47,918
2025	39,059
Thereafter	88,488
Total lease payments⁽²⁾	446,231
Less: Interest	91,473
Present value of operating lease liabilities⁽³⁾	$	354,758


Period	Total Number of Shares Purchased⁽¹⁾⁽²⁾	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs⁽¹⁾	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs⁽³⁾
December 29, 2019 through January 25, 2020	240,764	$	48.10	238,900	$	463,993,000
January 26, 2020 through February 22, 2020	224,831	$	54.37	224,400	$	451,795,000
February 23, 2020 through March 28, 2020	422,589	$	40.58	307,886	$	436,889,000
Total	888,184	$	46.11	771,186	$	436,889,000